ALEMBIC
Quarterly Results Analysis [Jun2025]
ALEMBIC Quarterly Results
| Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹50 Cr | ₹60 Cr | ₹58 Cr | ₹53 Cr | ₹51 Cr | ₹49 Cr | ₹39 Cr | ₹32 Cr |
| Expenses | ₹30 Cr | ₹33 Cr | ₹32 Cr | ₹33 Cr | ₹30 Cr | ₹25 Cr | ₹28 Cr | ₹22 Cr |
| Operating Income | ₹20 Cr | ₹27 Cr | ₹26 Cr | ₹20 Cr | ₹20 Cr | ₹24 Cr | ₹12 Cr | ₹10 Cr |
| Other Income | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹66 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹48 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr |
| Profit Before Tax | ₹20 Cr | ₹27 Cr | ₹27 Cr | ₹82 Cr | ₹19 Cr | ₹24 Cr | ₹11 Cr | ₹56 Cr |
| Profit After Tax | ₹18 Cr | ₹24 Cr | ₹26 Cr | ₹77 Cr | ₹17 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr |
| EPS | ₹2.40 | ₹2.67 | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC | 1.3% | -1.1% | -19.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | 3.6% | -7.8% |
| DIVIS LABORATORIES | 4.4% | 15.9% | 15.6% |
| CIPLA | -4.9% | -0.8% | 6.6% |
| TORRENT PHARMACEUTICALS | -0.6% | 1.8% | 15.7% |
| DR REDDYS LABORATORIES | -4.1% | -3.8% | -4.3% |
| MANKIND PHARMA | -3.1% | -3.3% | -8.6% |
| ZYDUS LIFESCIENCES | -2.9% | -1.6% | -0.5% |
| LUPIN | 2.1% | 1.3% | -8% |
ALEMBIC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -17.45 % |
| Y-o-Y | -2.03 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2025 | ₹50 Cr | -17.45 | |
| Mar2025 | ₹60 Cr | 4.06 | |
| Dec2024 | ₹58 Cr | 9.47 | |
| Sep2024 | ₹53 Cr | 4.19 | |
| Jun2024 | ₹51 Cr | 3.55 | |
| Mar2024 | ₹49 Cr | 24.72 | |
| Dec2023 | ₹39 Cr | 21.81 | |
| Sep2023 | ₹32 Cr | - | |
ALEMBIC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -28.37 % |
| Y-o-Y | -4.07 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2025 | ₹20 Cr | -28.37 | |
| Mar2025 | ₹27 Cr | 3.48 | |
| Dec2024 | ₹26 Cr | 34.90 | |
| Sep2024 | ₹20 Cr | -4.07 | |
| Jun2024 | ₹20 Cr | -15.53 | |
| Mar2024 | ₹24 Cr | 106.76 | |
| Dec2023 | ₹12 Cr | 15.07 | |
| Sep2023 | ₹10 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -13.21 % |
| Y-o-Y | -2.07 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2025 | 39.34% | -13.21 | |
| Mar2025 | 45.33% | -0.55 | |
| Dec2024 | 45.58% | 23.22 | |
| Sep2024 | 36.99% | -7.92 | |
| Jun2024 | 40.17% | -18.44 | |
| Mar2024 | 49.25% | 65.82 | |
| Dec2023 | 29.7% | -5.53 | |
| Sep2023 | 31.44% | - | |
ALEMBIC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -25.05 % |
| Y-o-Y | 2.18 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2025 | ₹18 Cr | -25.05 | |
| Mar2025 | ₹24 Cr | -8.97 | |
| Dec2024 | ₹26 Cr | -66.25 | |
| Sep2024 | ₹77 Cr | 343.80 | |
| Jun2024 | ₹17 Cr | -18.18 | |
| Mar2024 | ₹21 Cr | 114.62 | |
| Dec2023 | ₹10 Cr | -80.82 | |
| Sep2023 | ₹52 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -9.21 % |
| Y-o-Y | 4.31 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2025 | 35.78 % | -9.21 | |
| Mar2025 | 39.41 % | -12.50 | |
| Dec2024 | 45.04 % | -69.18 | |
| Sep2024 | 146.12 % | 326.01 | |
| Jun2024 | 34.3 % | -20.99 | |
| Mar2024 | 43.41 % | 72.06 | |
| Dec2023 | 25.23 % | -84.25 | |
| Sep2023 | 160.19 % | - | |
ALEMBIC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -10.11 % |
| Y-o-Y | 10.60 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2025 | ₹2.4 | -10.11 | |
| Mar2025 | ₹2.67 | 4.71 | |
| Dec2024 | ₹2.55 | -45.86 | |
| Sep2024 | ₹4.71 | 117.05 | |
| Jun2024 | ₹2.17 | -22.78 | |
| Mar2024 | ₹2.81 | 17.57 | |
| Dec2023 | ₹2.39 | -32.29 | |
| Sep2023 | ₹3.53 | - | |
You may also like the below Video Courses